Assessment of immunogenic activity of the cloned human rotavirus A WA strain
- Authors: Latyshev O.E.1, Eliseeva O.V.1, Kostina L.V.1, Alekseev K.P.1, Khametova K.M.1, Altaeva E.G.2, Verkhovsky O.A.2, Aliper T.I.1, Grebennikova T.V.1,3
-
Affiliations:
- National Research Center for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya
- Diagnostics and Prevention Research Institute for Human and Animal Diseases
- Peoples Frendship University of Russia
- Issue: Vol 64, No 4 (2019)
- Pages: 156-164
- Section: ORIGINAL RESEARCH
- Submitted: 16.12.2019
- Accepted: 16.12.2019
- Published: 20.08.2019
- URL: https://virusjour.crie.ru/jour/article/view/4
- DOI: https://doi.org/10.36233/0507-4088-2019-64-4-156-164
- ID: 4
Cite item
Full Text
Abstract
Introduction. Rotovirus infection (RVI) caused by the dsRNA-containing virus from genus Rotavirus, Reoviridae family, belonging to group A (RVA), is the cause of severe diarrhea in human and other mammalian species. Vaccination is the most effective way to reduce the incidence of RVI. At present, the effectiveness of using gnotobiotic piglets as a universal model for reproducing human rotavirus infection and assessing the quality of RVI vaccine preparations has been experimentally proven.
Goals and objectives. Evaluation of immunogenic activity of the cloned RVA Wa strain in the newborn Vietnamese pot-bellied piglets trial.
Material and methods. Development of viral preparations of the cloned human Wa strain PBA, development of human RVA rVP6, ELISA, polymerase chain reaction with reverse transcription, immunization and experimental infection of newborn piglets.
Results. The article presents the results of the experiment on double immunization of newborn piglets with native virus preparations with the infection activity 5.5 lg TCID50/ml, 3 cm3 per dose, HRV with adjuvant 500 pig per dose and mock preparation (control group) followed with experimental inoculation of all animals with virulent virus strain Wa G1P[8] human RVA with infectious activity of 5.5 lg TCID50/ml in 5 cm3 dose. Development of clinical signs of disease and animal death were observed only in control group. RT-PCR system to detect RVA RNA in rectal swabs, samples of small intestine and peripheral lymph nodes was developed. ELISA based on obtained human RVA rVP6 was developed and results on RVA-specific IgG-antibodies in serum samples of experimental piglets are presented.
Conclusion. In the course of the research, a high immunogenic activity of the native and purified virus of the cloned Wa RVA strain Wa was established and the possibility of its use as the main component of the RVI vaccine was confirmed. The possibility of using conventional newborn pigs instead of gnotobiotic piglets as an experimental model was demonstrated.
Keywords
About the authors
O. E. Latyshev
National Research Center for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya
Author for correspondence.
Email: oleglat80@mail.ru
ORCID iD: 0000-0002-5757-3809
Oleg E. Latyshev - PhD, Senior Scientist, Laboratory of molecular diagnostics.
Moscow, 123098.
Russian FederationO. V. Eliseeva
National Research Center for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya
Email: fake@neicon.ru
ORCID iD: 0000-0002-0723-9749
Moscow, 123098.
Russian FederationL. V. Kostina
National Research Center for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya
Email: fake@neicon.ru
ORCID iD: 0000-0002-9556-1454
Moscow, 123098.
Russian FederationK. P. Alekseev
National Research Center for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya
Email: fake@neicon.ru
ORCID iD: 0000-0001-9536-3127
Moscow, 123098.
Russian FederationK. M. Khametova
National Research Center for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya
Email: fake@neicon.ru
ORCID iD: 0000-0002-8461-600X
Moscow, 123098.
Russian FederationE. G. Altaeva
Diagnostics and Prevention Research Institute for Human and Animal Diseases
Email: fake@neicon.ru
ORCID iD: 0000-0001-7188-1704
Moscow, 123098.
Russian FederationO. A. Verkhovsky
Diagnostics and Prevention Research Institute for Human and Animal Diseases
Email: fake@neicon.ru
ORCID iD: 0000-0003-0784-9341
Moscow, 123098.
Russian FederationT. I. Aliper
National Research Center for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya
Email: fake@neicon.ru
ORCID iD: 0000-0002-5876-2425
Moscow, 123098.
Russian FederationT. V. Grebennikova
National Research Center for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya; Peoples Frendship University of Russia
Email: fake@neicon.ru
Moscow, 123098;Moscow, 117198.
Russian FederationReferences
- Львов Д.К., ред. Руководство по вирусологии: Вирусы и вирусные инфекции человека и животных. М.: МИА; 2013.
- Алипер Т.И., ред. Актуальные инфекционные болезни свиней: Руководство для студентов, научных и практических специалистов. М.: ЗооВетКнига; 2019.
- Gentsch J.R., Laird A.R., Bielfelt B., Griffin D.D., Banyai K., Ramachandran M., et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J. Infect. Dis. 2005; 192(Suppl. 1): 146-59. Doi: https://doi.org/10.1086/431499
- Matthijnssens J., Heylen E., Zeller M., Rahman M., Lemey P., Van Ranst M. Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol. Biol. Evol. 2010; 27(10): 2431-6. Doi: https://doi.org/10.1093/molbev/msq137
- Зайцева Е.В., Ольнева Т.А., Кулешов К.В., Подколзин А.Т., Шипулин Г.А., Кондратьева Л.М. и др. Результаты мониторинга антигенных типов ротавирусов гр. А на территории Российской Федерации в период 2011-2015 гг. Клиническая лабораторная диагностика. 2016; 61(7): 445-8. Doi: https://doi.org/10.18821/0869-2084-2016-61-7-445-448
- Алексеев К.П., Кальнов С.Л., Гребенникова Т.В., Алипер Т.И. Ротавирусная инфекция человека. Стратегии вакцинопрофилактики. Вопросы вирусологии. 2016; 61(3): 154-9.
- Денисюк Н.Б. Генетическая характеристика ротавирусов группы А, циркулирующих в Оренбургском регионе в сезон 2016¬2017 гг. Детские инфекции. 2017; 16(4): 42-5. Doi: https://doi.org/10.22627/2072-8107-2017-16-4-42-45 15.
- Zhang J., Liu H., Jia L., Payne D.C., Hall A.J., Xu Z., et al. Active, population-based surveillance for rotavirus gastroenteritis in Chinese children: Beijing Municipalityand Gansu Province, China. Pediatr. Infect. Dis. J. 2015; 34(1): 40-6. Doi: https://doi.org/10.1097/INF.0000000000000505
- Gomez M.M., da Silva M.F.M., Volotao E.M., Fialho A.M., Mazzoco C.S., Rocha M.S., et. al. G26P[19] rotavirus A strain causing acute gastroenteritis in the American continent. Mem. Inst. Oswaldo Cruz. 2018; 113(12): e180344. Doi: http://dx.doi.org/10.1590/0074-02760180344
- My P.V., Rabaa M.A., Donato C., Cowley D., Phat V.V., Dung T.T., et. al. Novel porcine-like human G26P[19] rotavirus identified in hospitalized paediatric diarrhoea patients in Ho Chi Minh City, Vietnam. J. Gen. Virol. 2014; 95(12): 2727-33. Doi: https://doi.org/10.1099/vir.0.068403-0
- PATH (2011-2016). Available at: https://www.path.org/programs/center-for-vaccine-innovation-and-access/rotaflash/
- Burnett E., Jonesteller C.L., Tate J.E., Yen C., Parashar U.D. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea. J. Infect. Dis. 2017; 215(11): 1666-72. Doi: https://doi.org/10.1093/infdis/jix186
- Crawford S.E., Ramani S., Tate J.E., Parashar U.D., Svensson L., Hagbom M., et al. Rotavirus infection. Nat. Rev. Dis. Primers. 2017; 3: 17083. Doi: https://doi.org/10.1038/nrdp.2017.83
- Tate J.E., Parashar U.D. Rotavirus vaccines in routine use. Clin. Infect. Dis. 2014; 59(9): 1291-301. Doi: https://doi.org/10.1093/cid/ciu564
- Хаметова К.М., Алексеев К.П., Южаков А.Г., Костина Л.В., Раев С.А., Мусиенко М.И. и др. Молекулярно-биологические свойства клонированного штамма Wa ротавируса А человека. Вопросы вирусологии. 2019; 64(1): 16-22.
- Ward L.A., Rosen B.I., Yuan L., Saif L.J. Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. J. Gen. Virol. 1996; 77(Pt. 7): 1431-41. Doi: https://doi.org/10.1099/0022-1317-77-7-1431
- Friess A.E., Sinowatz F., Skolek-Winnisch R., Trautner W. The placenta of the pig. II. The ultrastructure of the areolae. Anat. Embryol. (Berl.). 1981; 163(1): 43-53. Doi: https://doi.org/10.1007/bf00315769
- Lala P.K., Chatterjee-Hasrouni S., Kearns M., Montgomery B., Colavincenzo V. Immunobiology of the feto-maternal interface. Immunol. Rev. 1983; 75: 87-116. Doi: https://doi.org/104111/j.1600-065X.1983.tb01092.x
- Butler J.E., Lemke C.D., Weber P., Sinkora M., Lager K.M. Antibody repertoiredevelopment in fetal and neonatal piglets: XIX. Undiversified B cells with hydrophobic HCDR3s preferentially proliferate in the porcine reproductive and respiratory syndrome. J. Immunol. 2007; 178(10): 6320-31. Doi: https://doi.org/10.4049/jimmunol.178.10.6320
- Saif L.J., Fernandez F.M. Group A rotavirus veterinary vaccines. J. Infect. Dis. 1996; 174(Suppl. 1): 98-106. Doi: https://doi.org/10.1093/infdis/174.Supplement_1.S98
- Yuan L., Saif L.J. Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model. Vet. Immunol. Immunopathol. 2002; 87(3-4): 147-60. Doi: https://doi.org/10.1016/S0165-2427(02)00046-6
- Hammerberg C., Schurig G.G., Ochs D.L. Immunodeficiency in young pigs. Am. J. Vet. Res. 1989; 50(6): 868-74.
- Azevedo M.P., Vlasova A.N., Saif L.J. Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease. Expert. Rev. Vaccines. 2013; 12(2): 169-81. Doi: https://doi.org/10.1586/erv.13.3
- Babji S., Arumugam R., Sarvanabhavan A., Gentsch J.R., Kang G. Approach to molecular characterization of partially and completely untyped samples in an Indian rotavirus surveillance program. Vaccine. 2014; 32(Suppl. l): A84-8. Doi: https://doi.org/10.1016/j.vaccine.2014.04.024
- Gentsch J.R., Glass R.I., Woods P., Gouvea V, Gorziglia M., Flores J., et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J. Clin. Microbiol. 1992; 30(6): 1365-73.
- Close B., Banister K., Baumans V, Bernoth E.M., Bromage N., Bunyan J., et al. Recommendations for euthanasia of experimental animals: Part 2. DGXT of the European Commission. Lab. Anim. 1997; 31(1): 1-32. Doi: https://doi.org/10.1258/002367797780600297
- Сергеев В.А., Непоклонов Е.А., Алипер Т.И. Вирусы и вирусные вакцины. М.: Библионика; 2007.
- Yuan L., Ward L.A., Rosen B.I., To T.L., Saif L.J. Systematic and intestinal antibodysecreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of dis-ease. J. Virol. 1996; 70(5): 3075-83.
- Burns J.W., Krishnaney A.A., Vo P.T., Rouse R.V., Anderson L.J., Greenberg H.B. Analyses of homologous rotavirus infection in the mouse model. Virology. 1995; 207(1): 143-53. Doi: https://doi.org/10.1006/viro.1995.1060
- Patel M., Shane A.L., Parashar U.D., Jiang B., Gentsch J.R., Glass R.I. Oral rotavirus vaccines: how well will they work where they are needed most? J. Infect. Dis. 2009; 200(Suppl. 1): 39-48. Doi: https://doi.org/10.1086/605035
- Wagstrom E.A., Yoon K.J., Zimmerman J.J. Immune components in porcine mammary secretions. Viral Immunol. 2000; 13(3): 383-97. Doi: https://doi.org/10.1089/08828240050144699